- Report
- January 2023
- 180 Pages
Netherlands
From €2263EUR$2,490USD£1,952GBP
- Report
- February 2026
- 200 Pages
Australia
From €2718EUR$2,990USD£2,344GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2263EUR$2,490USD£1,952GBP
- Report
- May 2025
- 200 Pages
Global
From €2263EUR$2,490USD£1,952GBP
- Report
- March 2025
- 200 Pages
Global
From €2263EUR$2,490USD£1,952GBP
- Report
- July 2023
- 220 Pages
Global
From €1809EUR$1,990USD£1,560GBP
- Report
- February 2023
- 190 Pages
Sweden
From €2263EUR$2,490USD£1,952GBP
- Report
- January 2023
- 190 Pages
United Kingdom
From €2263EUR$2,490USD£1,952GBP
- Report
- January 2023
- 125 Pages
United States
From €2263EUR$2,490USD£1,952GBP
- Report
- October 2024
- 200 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- March 2024
- 200 Pages
Global
From €3772EUR$4,150USD£3,253GBP
- Report
- March 2024
- 200 Pages
Global
From €3772EUR$4,150USD£3,253GBP
- Report
- January 2024
- 200 Pages
Global
From €3772EUR$4,150USD£3,253GBP
- Report
- August 2023
- 145 Pages
Global
From €2863EUR$3,150USD£2,469GBP
- Report
- March 2022
- 300 Pages
Global
From €4545EUR$5,000USD£3,919GBP
- Report
- December 2024
- 85 Pages
Spain
From €3181EUR$3,500USD£2,743GBP
- Report
- October 2023
- 133 Pages
Europe
From €3636EUR$4,000USD£3,135GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1136EUR$1,250USD£980GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2727EUR$3,000USD£2,352GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1818EUR$2,000USD£1,568GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more